Learning Objectives:

1.    Describe the incidence of and when to suspect VITT 
2.    Review the available evidence linking COVID-19 vaccines to thrombosis with thrombocytopenia syndrome
3.    Discuss work up and management of suspected or confirmed VITT 

Session date: 
06/10/2021 - 8:00am to 9:00am CDT
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Participation

Please login or create an account to proceed.
Speaker Name: 
Dario Villamar, MD